Population-based laboratory surveillance of <it>Hafnia alvei </it>isolates in a large Canadian health region

<p>Abstract</p> <p>Background</p> <p>Hospital-based series have characterized <it>Hafnia alvei </it>primarily as an infrequent agent of polymicrobial nosocomial infections in males with underlying illness.</p> <p>Methods</p> <p>We con...

Full description

Bibliographic Details
Main Authors: Laupland Kevin B, Church Deirdre L, Ross Terry, Pitout Johann DD
Format: Article
Language:English
Published: BMC 2006-05-01
Series:Annals of Clinical Microbiology and Antimicrobials
Online Access:http://www.ann-clinmicrob.com/content/5/1/12
_version_ 1818806326900293632
author Laupland Kevin B
Church Deirdre L
Ross Terry
Pitout Johann DD
author_facet Laupland Kevin B
Church Deirdre L
Ross Terry
Pitout Johann DD
author_sort Laupland Kevin B
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Hospital-based series have characterized <it>Hafnia alvei </it>primarily as an infrequent agent of polymicrobial nosocomial infections in males with underlying illness.</p> <p>Methods</p> <p>We conducted population-based laboratory surveillance in the Calgary Health Region during 2000–2005 to define the incidence, demographic risk factors for acquisition, and anti-microbial susceptibilities of <it>Hafnia alvei </it>isolates.</p> <p>Results</p> <p>A total of 138 patients with <it>Hafnia alvei </it>isolates were identified (2.1/100,000/year) and two-thirds were of community onset. Older age and female gender were important risk factors for acquisition. The most common focus of isolation was urine in 112 (81%), followed by lower respiratory tract in 10 (7%), and soft tissue in 5 (4%), and the majority (94; 68%) were mono-microbial. Most isolates were resistant to ampicillin (111;80%), cephalothin (106; 77%), amoxicillin/clavulanate (98; 71%), and cefazolin (95; 69%) but none to imipenem or ciprofloxacin.</p> <p>Conclusion</p> <p><it>Hafnia alvei </it>was most commonly isolated as a mono-microbial etiology from the urinary tract in women from the community. This study highlights the importance of population-based studies in accurately defining the epidemiology of an infectious disease.</p>
first_indexed 2024-12-18T19:08:00Z
format Article
id doaj.art-662b7561d6244e17b95e7daca823b625
institution Directory Open Access Journal
issn 1476-0711
language English
last_indexed 2024-12-18T19:08:00Z
publishDate 2006-05-01
publisher BMC
record_format Article
series Annals of Clinical Microbiology and Antimicrobials
spelling doaj.art-662b7561d6244e17b95e7daca823b6252022-12-21T20:56:22ZengBMCAnnals of Clinical Microbiology and Antimicrobials1476-07112006-05-01511210.1186/1476-0711-5-12Population-based laboratory surveillance of <it>Hafnia alvei </it>isolates in a large Canadian health regionLaupland Kevin BChurch Deirdre LRoss TerryPitout Johann DD<p>Abstract</p> <p>Background</p> <p>Hospital-based series have characterized <it>Hafnia alvei </it>primarily as an infrequent agent of polymicrobial nosocomial infections in males with underlying illness.</p> <p>Methods</p> <p>We conducted population-based laboratory surveillance in the Calgary Health Region during 2000–2005 to define the incidence, demographic risk factors for acquisition, and anti-microbial susceptibilities of <it>Hafnia alvei </it>isolates.</p> <p>Results</p> <p>A total of 138 patients with <it>Hafnia alvei </it>isolates were identified (2.1/100,000/year) and two-thirds were of community onset. Older age and female gender were important risk factors for acquisition. The most common focus of isolation was urine in 112 (81%), followed by lower respiratory tract in 10 (7%), and soft tissue in 5 (4%), and the majority (94; 68%) were mono-microbial. Most isolates were resistant to ampicillin (111;80%), cephalothin (106; 77%), amoxicillin/clavulanate (98; 71%), and cefazolin (95; 69%) but none to imipenem or ciprofloxacin.</p> <p>Conclusion</p> <p><it>Hafnia alvei </it>was most commonly isolated as a mono-microbial etiology from the urinary tract in women from the community. This study highlights the importance of population-based studies in accurately defining the epidemiology of an infectious disease.</p>http://www.ann-clinmicrob.com/content/5/1/12
spellingShingle Laupland Kevin B
Church Deirdre L
Ross Terry
Pitout Johann DD
Population-based laboratory surveillance of <it>Hafnia alvei </it>isolates in a large Canadian health region
Annals of Clinical Microbiology and Antimicrobials
title Population-based laboratory surveillance of <it>Hafnia alvei </it>isolates in a large Canadian health region
title_full Population-based laboratory surveillance of <it>Hafnia alvei </it>isolates in a large Canadian health region
title_fullStr Population-based laboratory surveillance of <it>Hafnia alvei </it>isolates in a large Canadian health region
title_full_unstemmed Population-based laboratory surveillance of <it>Hafnia alvei </it>isolates in a large Canadian health region
title_short Population-based laboratory surveillance of <it>Hafnia alvei </it>isolates in a large Canadian health region
title_sort population based laboratory surveillance of it hafnia alvei it isolates in a large canadian health region
url http://www.ann-clinmicrob.com/content/5/1/12
work_keys_str_mv AT lauplandkevinb populationbasedlaboratorysurveillanceofithafniaalveiitisolatesinalargecanadianhealthregion
AT churchdeirdrel populationbasedlaboratorysurveillanceofithafniaalveiitisolatesinalargecanadianhealthregion
AT rossterry populationbasedlaboratorysurveillanceofithafniaalveiitisolatesinalargecanadianhealthregion
AT pitoutjohanndd populationbasedlaboratorysurveillanceofithafniaalveiitisolatesinalargecanadianhealthregion